«
‹
1
...
1076
1077
1078
1079
1080
1081
1082
1083
1084
...
5099
›
»
Page 1080 of 5099 · 254917 entries
Go to
| PDB ID | Title | official curves | Structure unit | Experimental Method |
|---|---|---|---|---|
| 2we1 | EBV dUTPase mutant Asp131Asn with bound dUMP | 1 | 1 | X-RAY DIFFRACTION |
| 2we2 | EBV dUTPase double mutant Gly78Asp-Asp131Ser with dUMP | 1 | 1 | X-RAY DIFFRACTION |
| 2we3 | EBV dUTPase inactive mutant deleted of motif V | 1 | 1 | X-RAY DIFFRACTION |
| 2we4 | Carbamate kinase from Enterococcus faecalis bound to a sulfate ion and two water molecules, which mimic the substrate carbamyl phosphate | 2 | 2 | X-RAY DIFFRACTION |
| 2we5 | Carbamate kinase from Enterococcus faecalis bound to MgADP | 2 | 2 | X-RAY DIFFRACTION |
| 2we6 | Crystal Structure of Plasmodium falciparum Ubiquitin Carboxyl- terminal Hydrolase 3 (UCHL3) | 2 | 2 | X-RAY DIFFRACTION |
| 2we7 | Crystal structure of Mycobacterium tuberculosis Rv0376c homologue from Mycobacterium smegmatis | 2 | 2 | X-RAY DIFFRACTION |
| 2we8 | Crystal structure of Mycobacterium tuberculosis Rv0376c homologue from Mycobacterium smegmatis | 2 | 2 | X-RAY DIFFRACTION |
| 2we9 | Crystal structure of Rv0371c from Mycobacterium tuberculosis H37Rv | 2 | 2 | X-RAY DIFFRACTION |
| 2wea | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | 1 | 1 | X-RAY DIFFRACTION |
| 2web | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L-VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT | 1 | 1 | X-RAY DIFFRACTION |
| 2wec | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1-NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT | 1 | 1 | X-RAY DIFFRACTION |
| 2wed | ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | 1 | 1 | X-RAY DIFFRACTION |
| 2wee | Crystal structure of Rv0371c from Mycobacterium tuberculosis H37Rv | 2 | 2 | X-RAY DIFFRACTION |
| 2wef | Human 3'(2'), 5'-bisphosphate nucleotidase 1 (BPNT1) in complex with AMP, PO4 and Magnesium | 1 | 1 | X-RAY DIFFRACTION |
| 2weg | Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors | 1 | 1 | X-RAY DIFFRACTION |
| 2weh | Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors | 1 | 1 | X-RAY DIFFRACTION |
| 2wei | Crystal structure of the kinase domain of Cryptosporidium parvum calcium dependent protein kinase in complex with 3-MB-PP1 | 1 | 1 | X-RAY DIFFRACTION |
| 2wej | Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors | 1 | 1 | X-RAY DIFFRACTION |
| 2wek | Crystal structure of the human MGC45594 gene product in complex with diclofenac | 2 | 2 | X-RAY DIFFRACTION |
| 2wel | Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin | 1 | 1 | X-RAY DIFFRACTION |
| 2weo | Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors | 1 | 1 | X-RAY DIFFRACTION |
| 2wep | Yeast Hsp90 N-terminal domain LI-IV mutant with ADP | 1 | 1 | X-RAY DIFFRACTION |
| 2weq | Yeast Hsp90 N-terminal domain LI-IV mutant with Geldanamycin | 1 | 1 | X-RAY DIFFRACTION |
| 2wer | Yeast Hsp90 N-terminal domain LI-IV mutant with Radicicol | 2 | 2 | X-RAY DIFFRACTION |
| 2wes | Crystal structures of mutant E46Q of tryptophan 5-halogenase (PyrH) | 2 | 2 | X-RAY DIFFRACTION |
| 2wet | Crystal structure of tryptophan 5-halogenase (PyrH) complex with FAD (tryptophan) | 2 | 2 | X-RAY DIFFRACTION |
| 2weu | Crystal structure of tryptophan 5-halogenase (PyrH) complex with substrate tryptophan | 2 | 2 | X-RAY DIFFRACTION |
| 2wev | Truncation and Optimisation of Peptide Inhibitors of CDK2, Cyclin A Through Structure Guided Design | 2 | 2 | X-RAY DIFFRACTION |
| 2wew | Crystal structure of human apoM in complex with myristic acid | 1 | 1 | X-RAY DIFFRACTION |
| 2wex | Crystal structure of human apoM in complex with glycerol 1- myristic acid | 1 | 1 | X-RAY DIFFRACTION |
| 2wey | Human PDE-papaverine complex obtained by ligand soaking of cross- linked protein crystals | 2 | 2 | X-RAY DIFFRACTION |
| 2wez | Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-4-(2-oxo-1- pyrrolidinyl)-1H-indole-6-carboxamide | 1 | 1 | X-RAY DIFFRACTION |
| 2wf0 | Human BACE-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-8-(2-oxo-1-pyrrolidinyl)-6-quinolinecarboxamide | 1 | 1 | X-RAY DIFFRACTION |
| 2wf1 | Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl(methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4- dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9-carboxamide 2,2- dioxide | 1 | 1 | X-RAY DIFFRACTION |
| 2wf2 | Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4,7, 8-tetrahydro-1H,6H-(1,2,5)thiadiazepino(5,4,3-de)quinoxaline-10- carboxamide 2,2-dioxide | 1 | 1 | X-RAY DIFFRACTION |
| 2wf3 | Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-1, 3,4,5-tetrahydro-2,1-benzothiazepine-8-carboxamide 2,2-dioxide | 1 | 1 | X-RAY DIFFRACTION |
| 2wf4 | Human BACE-1 in complex with 6-ethyl-1-methyl-N-((1S)-2-oxo-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl)-1,3,4,6- tetrahydro(1,2)thiazepino(5,4,3-cd)indole-8-carboxamide 2,2-dioxide | 1 | 1 | X-RAY DIFFRACTION |
| 2wf5 | Structure of Beta-Phosphoglucomutase inhibited with Glucose-6-phosphate and trifluoromagnesate | 1 | 1 | X-RAY DIFFRACTION |
| 2wf6 | Structure of Beta-Phosphoglucomutase inhibited with Glucose-6-phosphate and Aluminium tetrafluoride | 1 | 1 | X-RAY DIFFRACTION |
| 2wf7 | Structure of Beta-Phosphoglucomutase inhibited with Glucose-6- phosphonate and Aluminium tetrafluoride | 1 | 1 | X-RAY DIFFRACTION |
| 2wf8 | Structure of Beta-Phosphoglucomutase inhibited with Glucose-6- phosphate, Glucose-1-phosphate and Beryllium trifluoride | 1 | 1 | X-RAY DIFFRACTION |
| 2wf9 | Structure of Beta-Phosphoglucomutase inhibited with Glucose-6- phosphate, and Beryllium trifluoride, crystal form 2 | 1 | 1 | X-RAY DIFFRACTION |
| 2wfa | Structure of Beta-Phosphoglucomutase inhibited with Beryllium trifluoride, in an open conformation. | 1 | 1 | X-RAY DIFFRACTION |
| 2wfb | High resolution structure of the apo form of the orange protein (ORP) from Desulfovibrio gigas | 1 | 1 | X-RAY DIFFRACTION |
| 2wfc | Crystal structure of peroxiredoxin 5 from Arenicola Marina | 2 | 2 | X-RAY DIFFRACTION |
| 2wfd | Structure of the human cytosolic leucyl-tRNA synthetase editing domain | 1 | 1 | X-RAY DIFFRACTION |
| 2wfe | Structure of the Candida albicans cytosolic leucyl-tRNA synthetase editing domain | 4 | 4 | X-RAY DIFFRACTION |
| 2wff | Equine Rhinitis A Virus | 1 | 5 | X-RAY DIFFRACTION |
| 2wfg | Structure of the Candida albicans cytosolic leucyl-tRNA synthetase editing domain bound to a benzoxaborole-AMP adduct | 1 | 1 | X-RAY DIFFRACTION |